Evaluating deterioration in patients with acute COVID-19
The Lancet Respiratory Medicine in conversation with
English - January 12, 2021 00:00 - 8 minutes - 5.87 MB - ★★★★★ - 1 ratingLife Sciences Science Education lungs pulmonary smoking vape flu Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Treatment options in patients with systemic sclerosis-associated interstitial lung disease
Next Episode: Interferon treatment and COVID-19
Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30559-2/fulltext
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv